⚕️ For informational purposes only. Not medical advice. Learn more

🧪
biochemistry

Creatine Kinase-MB

CK-MB· also: CKMB, Creatine Kinase MB

Clinical Overview

CK-MB is an isoenzyme of creatine kinase found predominantly in cardiac muscle. It was the standard cardiac biomarker before troponin became widely available. CK-MB rises 4–6 hours after MI, peaks at 12–24 hours, and normalizes within 48–72 hours — faster than troponin. Its shorter window of positivity is used to diagnose re-infarction.

Why This Test Matters

CK-MB has largely been replaced by high-sensitivity troponin for MI diagnosis, which is more specific and sensitive. However, CK-MB retains clinical utility for timing myocardial injury (its faster return to normal allows detection of a second MI when troponin remains elevated from the first) and for assessing completeness of reperfusion after thrombolysis (an early CK-MB peak after thrombolysis suggests successful reperfusion).

Reference RangesWHO/IFCC standards

Age GroupReference RangeUnitNotes
Adults (18–64)0 – 25U/L

Also reported in: %.

What Causes Abnormal Results?

High CK-MB Causes

  • Acute myocardial infarction
  • Myocarditis
  • Cardiac surgery or cardioversion
  • Skeletal muscle trauma (when total CK is also very high)
  • Rhabdomyolysis (a small amount of CK-MB is in skeletal muscle)

Low CK-MB Causes

  • Not clinically significant (low or undetectable is normal)

Signs & Symptoms to Watch For

Chest painShortness of breathSyncopePalpitations

How to Prepare for This Test

No special preparation. Serial measurements are most useful — typically at 0, 6, and 12 hours in suspected MI.

Factors That Can Affect Results

  • Skeletal muscle injury with high CK-MB fraction (macro-CK, athlete training)
  • Hemolysis
  • Myopathy (some skeletal muscle diseases express CK-MB)
📢 Ad Placeholder (responsive)

Related Topics

cardiacheart attackMIcardiac enzymes

Frequently Asked Questions

Is CK-MB still useful when troponin is available?

CK-MB is still used in specific situations: (1) detecting re-infarction in a patient with a recent MI where troponin remains elevated — a new CK-MB rise after normalization confirms a new event; (2) assessing reperfusion after thrombolysis — a rapid, early CK-MB peak (washout phenomenon) suggests successful clot dissolution; (3) estimating infarct size. For initial MI diagnosis, high-sensitivity troponin is always preferred.

Related Tests